These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36353633)

  • 1. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
    Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
    Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
    Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
    Ouaguia L; Dufeu-Duchesne T; Leroy V; Decaens T; Reiser JB; Sosa Cuevas E; Durantel D; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(12):e1208. PubMed ID: 33312564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
    Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
    Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDCA1
    Sosa Cuevas E; Ouaguia L; Mouret S; Charles J; De Fraipont F; Manches O; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(11):e1190. PubMed ID: 33282290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
    Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2019; 10():112. PubMed ID: 30778353
    [No Abstract]   [Full Text] [Related]  

  • 7. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.
    Sosa Cuevas E; Saas P; Aspord C
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
    Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
    Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
    Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
    Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets.
    Lundberg K; Rydnert F; Broos S; Andersson M; Greiff L; Lindstedt M
    PLoS One; 2016; 11(2):e0148838. PubMed ID: 26863539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80
    Sosa Cuevas E; Bendriss-Vermare N; Mouret S; De Fraipont F; Charles J; Valladeau-Guilemond J; Chaperot L; Aspord C
    Clin Transl Immunology; 2022; 11(5):e1382. PubMed ID: 35517992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
    Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
    Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells.
    Hsu SC; Chen CH; Tsai SH; Kawasaki H; Hung CH; Chu YT; Chang HW; Zhou Y; Fu J; Plunkett B; Su SN; Vieths S; Lee RT; Lee YC; Huang SK
    J Biol Chem; 2010 Mar; 285(11):7903-10. PubMed ID: 20080962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
    J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer.
    Jin W; Li C; Du T; Hu K; Huang X; Hu Q
    Virology; 2014 Jun; 458-459():83-92. PubMed ID: 24928041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses.
    Besson S; Laurin D; Chauvière C; Thépaut M; Kleman JP; Pezet M; Manches O; Fieschi F; Aspord C; Fender P
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN.
    Meyer S; van Liempt E; Imberty A; van Kooyk Y; Geyer H; Geyer R; van Die I
    J Biol Chem; 2005 Nov; 280(45):37349-59. PubMed ID: 16155001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.